feed,title,long_url,short_url
Benzinga,AstraZeneca Beefs Up Its Endocrine Disease Pipeline With Amolyt Pharma Deal Worth $1.05B,https://benzinga.com/general/biotech/24/03/37709624/astrazeneca-beefs-up-its-endocrine-disease-pipeline-with-amolyt-pharma-deal-worth-1-05b,https://da.gd/IytJK3
